323 related articles for article (PubMed ID: 30827925)
1. Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities.
Önnerhag K; Dreja K; Nilsson PM; Lindgren S
Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):542-550. PubMed ID: 30827925
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD).
Önnerhag K; Hartman H; Nilsson PM; Lindgren S
Scand J Gastroenterol; 2019 Mar; 54(3):328-334. PubMed ID: 30907181
[No Abstract] [Full Text] [Related]
3. Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD.
Önnerhag K; Nilsson PM; Lindgren S
Scand J Gastroenterol; 2014 Sep; 49(9):1111-8. PubMed ID: 24990583
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
Chinnadurai R; Ritchie J; Green D; Kalra PA
Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
[TBL] [Abstract][Full Text] [Related]
5. Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west?
Zhang M; Lin S; Wang MF; Huang JF; Liu SY; Wu SM; Zhang HY; Wu ZM; Liu WY; Zhang DC; Hao CM; Zhu YY; Zheng MH; Wang XZ
BMC Gastroenterol; 2020 May; 20(1):139. PubMed ID: 32375660
[TBL] [Abstract][Full Text] [Related]
6. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study.
Sinn DH; Kang D; Jang HR; Gu S; Cho SJ; Paik SW; Ryu S; Chang Y; Lazo M; Guallar E; Cho J; Gwak GY
J Hepatol; 2017 Dec; 67(6):1274-1280. PubMed ID: 28870674
[TBL] [Abstract][Full Text] [Related]
7. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.
Chinnadurai R; Chrysochou C; Kalra PA
Nephron; 2019; 141(1):24-30. PubMed ID: 30384370
[TBL] [Abstract][Full Text] [Related]
8. The correlation between fatty liver disease and chronic kidney disease.
Chen PC; Kao WY; Cheng YL; Wang YJ; Hou MC; Wu JC; Su CW
J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):42-50. PubMed ID: 30876789
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study.
Park H; Dawwas GK; Liu X; Nguyen MH
J Intern Med; 2019 Dec; 286(6):711-722. PubMed ID: 31359543
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
Mantovani A; Zaza G; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
Metabolism; 2018 Feb; 79():64-76. PubMed ID: 29137912
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD).
Roderburg C; Krieg S; Krieg A; Demir M; Luedde T; Kostev K; Loosen SH
Eur J Med Res; 2023 Apr; 28(1):153. PubMed ID: 37062837
[TBL] [Abstract][Full Text] [Related]
12. FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease.
Seko Y; Yano K; Takahashi A; Okishio S; Kataoka S; Okuda K; Mizuno N; Takemura M; Taketani H; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Okanoue T; Itoh Y
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881781
[TBL] [Abstract][Full Text] [Related]
13. MAFLD and risk of CKD.
Sun DQ; Jin Y; Wang TY; Zheng KI; Rios RS; Zhang HY; Targher G; Byrne CD; Yuan WJ; Zheng MH
Metabolism; 2021 Feb; 115():154433. PubMed ID: 33212070
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
[TBL] [Abstract][Full Text] [Related]
15. The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank.
Hydes TJ; Kennedy OJ; Buchanan R; Cuthbertson DJ; Parkes J; Fraser SDS; Roderick P
BMC Med; 2023 May; 21(1):185. PubMed ID: 37198624
[TBL] [Abstract][Full Text] [Related]
16. Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis.
Bellinato F; Goio I; Malara G; Rosato A; Targher G; Girolomoni G; Gisondi P
J Cutan Med Surg; 2022; 26(3):249-255. PubMed ID: 34894782
[TBL] [Abstract][Full Text] [Related]
17. New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate With the Risk of Incident Chronic Kidney Disease.
Zuo G; Xuan L; Xin Z; Xu Y; Lu J; Chen Y; Dai M; Zhang D; Wang W; Li M; Bi Y; Ning G; Xu M
J Clin Endocrinol Metab; 2021 Sep; 106(10):e3957-e3968. PubMed ID: 34125886
[TBL] [Abstract][Full Text] [Related]
18. The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study.
Huh JH; Kim JY; Choi E; Kim JS; Chang Y; Sung KC
PLoS One; 2017; 12(7):e0180951. PubMed ID: 28738057
[TBL] [Abstract][Full Text] [Related]
19. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.
Musso G; Gambino R; Tabibian JH; Ekstedt M; Kechagias S; Hamaguchi M; Hultcrantz R; Hagström H; Yoon SK; Charatcharoenwitthaya P; George J; Barrera F; Hafliðadóttir S; Björnsson ES; Armstrong MJ; Hopkins LJ; Gao X; Francque S; Verrijken A; Yilmaz Y; Lindor KD; Charlton M; Haring R; Lerch MM; Rettig R; Völzke H; Ryu S; Li G; Wong LL; Machado M; Cortez-Pinto H; Yasui K; Cassader M
PLoS Med; 2014 Jul; 11(7):e1001680. PubMed ID: 25050550
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease.
Sun C; Goh GB; Chow WC; Chan WK; Wong GL; Seto WK; Huang YH; Lin HC; Lee IC; Lee HW; Kim SU; Wong VW; Fan JG
Hepatobiliary Pancreat Dis Int; 2024 Jun; 23(3):241-248. PubMed ID: 37620227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
